Moderna in talks with FDA over Phase 4 Covid vaccine data

Photo: Kyle LaHucik for Endpoints News May 1, 2026 02:08 PM EDTUpdated 02:44 PM R&DPharmaFDA+Coronavirus Mod­er­na in talks with FDA over post-mar­ket­ing Covid shot da­ta, with eyes on wider ac­cess Max Bayer Senior Reporter Mod­er­na said it’s work­ing with US reg­u­la­tors to pro­vide post-mar­ket­ing da­ta on its Covid-19 vac­cines that could re­store their use to a wider group af­ter … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER